The Current Ratio as of November 2024 (TTM) for Satsuma Pharmaceuticals, Inc. (STSA) is 6.75

According to Satsuma Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 6.75. This represents a change of -19.41% compared to the average of 8.38 of the last 4 quarters.

Satsuma Pharmaceuticals, Inc. (STSA) Historical Current Ratio (quarterly & annually)

How has STSA Current Ratio performed in the past?

The mean historical Current Ratio of Satsuma Pharmaceuticals, Inc. over the last ten years is 7.66. The current 6.75 Current Ratio has changed 8.72% with respect to the historical average. Over the past ten years (40 quarters), STSA's Current Ratio was at its highest in in the March 2021 quarter at 25.50. The Current Ratio was at its lowest in in the September 2018 quarter at 0.

Satsuma Pharmaceuticals, Inc. (STSA) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Satsuma Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Satsuma Pharmaceuticals, Inc. (STSA) Average Current Ratio

How has STSA Current Ratio performed in the past?

The current Current Ratio of Satsuma Pharmaceuticals, Inc. (STSA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Satsuma Pharmaceuticals, Inc. (STSA) Current Ratio vs. Peers

How is STSA’s Current Ratio compared to its peers?

Satsuma Pharmaceuticals, Inc.’s Current Ratio is greater than ZIVO Bioscience, Inc. (0.17), less than Theseus Pharmaceuticals, Inc. (29.93), less than Erasca, Inc. (11.00), greater than Forte Biosciences, Inc. (2.06), greater than Applied Molecular Transport Inc. (4.99), greater than SAB Biotherapeutics, Inc. (3.69), greater than Senti Biosciences, Inc. (1.92), less than Cingulate Inc. (7.35K), greater than Bellicum Pharmaceuticals, Inc. (3.04), greater than Hillstream BioPharma, Inc. (2.25), less than Kronos Bio, Inc. (8.32), greater than Cyclerion Therapeutics, Inc. (5.07), less than Larimar Therapeutics, Inc. (13.10), greater than Addex Therapeutics Ltd (4.97), greater than Achilles Therapeutics plc (6.04), greater than Assembly Biosciences, Inc. (2.36), greater than CytomX Therapeutics, Inc. (1.04), less than Instil Bio, Inc. (12.90), less than Neoleukin Therapeutics, Inc. (15.33), less than PMV Pharmaceuticals, Inc. (13.98), less than Eliem Therapeutics, Inc. (60.41), less than MediciNova, Inc. (16.66), less than Pharvaris N.V. (19.08), less than PepGen Inc. (8.47),

Build a custom stock screener for Satsuma Pharmaceuticals, Inc. (STSA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Satsuma Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Satsuma Pharmaceuticals, Inc. (STSA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Satsuma Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.